Restrospective Study of Outcomes of Patients with WHO Groups 1 and 3 Pulmonary Hypertension Treated with High-Dose Inhaled Treprostinil
Research Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
United Therapeutics Corporation
Start Date
February 28, 2018
End Date
November 8, 2024
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
United Therapeutics Corporation
Start Date
February 28, 2018
End Date
November 8, 2024